Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-14

Clinical Trial Update: Ibuprofen Plus Acetaminophen for Enhanced Pain Reduction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial updating on the use of ibuprofen plus acetaminophen for enhanced acute pain reduction is underway, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetaminophen (Acetaminophen)
  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: New York City Health and Hospitals Corporation | Conditions: Pain, Acute | Phase 4 | Status: UNKNOWN